CSF3 and Alzheimer disease: We have previously reported that AD transgenic mice given 3 weeks of GCSF or GMCSF injections showed CNS enhancements in hippocampal neurogenesis, microglial activation/Aβ degradation, and synaptogenesis (Sanchez-Ramos et al., 2009; Boyd et al., 2010).